[HTML][HTML] COVID-19 mRNA vaccines: lessons learned from the registrational trials and global vaccination campaign
MN Mead, S Seneff, R Wolfinger, J Rose… - Cureus, 2024 - ncbi.nlm.nih.gov
Our understanding of COVID-19 vaccinations and their impact on health and mortality has
evolved substantially since the first vaccine rollouts. Published reports from the original …
evolved substantially since the first vaccine rollouts. Published reports from the original …
[HTML][HTML] COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
MN Mead, S Seneff, R Wolfinger, J Rose… - International Journal of …, 2024 - ijvtpr.com
Our understanding of COVID-19 synthetic, modified mRNA (modmRNA) products and their
public health impact has evolved substantially since December 2020. Published reports …
public health impact has evolved substantially since December 2020. Published reports …
[HTML][HTML] SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination
The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has led to almost seven million deaths worldwide. SARS-CoV-2 causes …
(SARS-CoV-2) has led to almost seven million deaths worldwide. SARS-CoV-2 causes …
[HTML][HTML] COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
MN Mead, S Seneff, J Rose, R Wolfinger… - International Journal of …, 2024 - ijvtpr.com
The COVID-19 modified mRNA (modmRNA) lipid nanoparticle-based “vaccines” are not
classical antigen-based vaccines but instead prodrugs informed by gene therapy …
classical antigen-based vaccines but instead prodrugs informed by gene therapy …
[HTML][HTML] Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
M Gibo, S Kojima, A Fujisawa, T Kikuchi, M Fukushima - Cureus, 2024 - ncbi.nlm.nih.gov
During the COVID-19 pandemic, excess deaths including cancer have become a concern in
Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age …
Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age …
[HTML][HTML] COVID-19 Modified mRNA “Vaccines” Part 1: Lessons Learned from Clinical Trials, Mass Vaccination, and Censorship by the Bio-Pharmaceutical Complex
MN Mead, S Seneff, R Wolfinger, J Rose… - International Journal of …, 2023 - mail.ijvtpr.com
Our understanding of COVID-19 synthetic, modified mRNA (modmRNA) products and their
public health impact has evolved substantially since December 2020. Published reports …
public health impact has evolved substantially since December 2020. Published reports …
[HTML][HTML] Thrombosis With Thrombocytopenia and Post-COVID-Vaccination Syndrome With Anti-G-Protein-Coupled Receptor (GPCR) Antibodies Treated With …
M Mantovani, R Grossi, G Di Fede, P Bellavite - Cureus, 2024 - ncbi.nlm.nih.gov
We present the case of a female who developed cerebral venous thrombosis with
thrombocytopenia after inoculation with the anti-coronavirus disease 2019 (COVID-19) …
thrombocytopenia after inoculation with the anti-coronavirus disease 2019 (COVID-19) …
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
G Miki, K Seiji, F Akinori, K Takayuki, F Masanori - Cureus, 2024 - search.proquest.com
During the COVID-19 pandemic, excess deaths including cancer have become a concern in
Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age …
Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age …
[HTML][HTML] Case Report: New-onset relapsing-remitting multiple sclerosis with positive Uhthoff phenomenon after second BNT162b2 dose
J Finsterer, N D'Souza - F1000Research, 2024 - f1000research.com
Objectives new-onset relapsing-remitting multiple sclerosis (RRMS) has rarely been
communicated as a side effect of SARS-CoV-2 vaccination (SC2V). Here we report a patient …
communicated as a side effect of SARS-CoV-2 vaccination (SC2V). Here we report a patient …
[PDF][PDF] Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures
J Ueda, H Motohashi, Y Hirai, K Yamamoto… - 2024 - veridica.ro
The coronavirus pandemic was declared by the World Health Organization (WHO) in 2020,
and a global genetic vaccination program has been rapidly implemented as a fundamental …
and a global genetic vaccination program has been rapidly implemented as a fundamental …